Data Licensing with Millennium Health for analyzing drug tests

The Centers for Disease Control and Prevention is forecasting a data licensing agreement with Millennium Health to support the analysis of drug test results, leveraging specialized laboratory data for public health surveillance and program evaluation. This initiative falls under NAICS code 541512, indicating it involves computer systems design and related services, and is intended to enhance the CDC’s capacity to interpret toxicology and drug use patterns across populations. The contracting officer and program point of contact are both listed with the same email address, suggesting centralized oversight, though the contracting officer’s name is currently undetermined. The place of performance and physical office address are unspecified, implying the work will be conducted remotely or through digital data exchanges. The forecast was posted in May 2026, signaling a planned future procurement with no set-aside classification indicated, meaning it is open to all eligible vendors.